In another study on the mechanism of lung cancer, it was found that lncRNA H19 may inhibit the transcription level of FTH1 by competitively binding miRNA-19b-3p, so as to protect lung cancer cells from iron death injury, thus weakening the effect of anticancer drugs (24). This evidence concerns the gene H19 and lung carcinoma.